Rossing P - Search Results

1

[Hypertension in patients with diabetes].

Poulsen PL, Hansen KW, Gaede PH, Rossing P. Poulsen PL, et al. Among authors: rossing p. Ugeskr Laeger. 2009 Jun 8;171(24):2031-4. Ugeskr Laeger. 2009. PMID: 19523370 Danish.

2

[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].

Gall MA, Rossing P, Skøtt P, Hommel EE, Mathiesen ER, Gerdes LU, Lauritzen M, Vølund A, Faergeman O, Beck-Nielsen H, et al. Gall MA, et al. Among authors: rossing p. Ugeskr Laeger. 1993 Mar 1;155(9):636-41. Ugeskr Laeger. 1993. PMID: 8447032 Clinical Trial. Danish. No abstract available.

3

[Diabetic nephropathy. Unchanged occurrence in patients with insulin-dependent diabetes mellitus].

Rossing P, Rossing K, Jacobsen P, Parving HH. Rossing P, et al. Among authors: rossing k. Ugeskr Laeger. 1996 Oct 14;158(42):5940-3. Ugeskr Laeger. 1996. PMID: 8928282 Danish.

4

[Risk factors for mortality in patients with insulin-dependent diabetes].

Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Rossing P, et al. Ugeskr Laeger. 1998 Feb 23;160(9):1315-9. Ugeskr Laeger. 1998. PMID: 9495080 Danish.

5

Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.

Rossing P. Rossing P. Diabet Med. 1998 Nov;15(11):900-19. doi: 10.1002/(SICI)1096-9136(1998110)15:11<900::AID-DIA709>3.0.CO;2-0. Diabet Med. 1998. PMID: 9827844 Review.

6

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Andersen S, et al. Among authors: rossing p. Kidney Int. 2000 Feb;57(2):601-6. doi: 10.1046/j.1523-1755.2000.00880.x. Kidney Int. 2000. PMID: 10652037 Free article. Clinical Trial.

7

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Hovind P, et al. Among authors: rossing p. Kidney Int. 2001 Jul;60(1):277-83. doi: 10.1046/j.1523-1755.2001.00797.x. Kidney Int. 2001. PMID: 11422762 Free article. Clinical Trial.

8

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH. Hovind P, et al. Among authors: rossing p. Kidney Int. 2004 Sep;66(3):1180-6. doi: 10.1111/j.1523-1755.2004.00870.x. Kidney Int. 2004. PMID: 15327415 Free article.

9

[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication].

Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Hovind P, et al. Among authors: rossing p. Ugeskr Laeger. 2005 Jan 3;167(1):57-60. Ugeskr Laeger. 2005. PMID: 15675170 Danish. No abstract available.

10

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.

Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH. Rossing P, et al. Among authors: rossing k. Diabetes Care. 2006 May;29(5):1024-30. doi: 10.2337/diacare.2951024. Diabetes Care. 2006. PMID: 16644632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters